down arrow

Huaren Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000SW1
CNY
3.56
0.02 (0.56%)

Dec 04

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Huaren Pharmaceutical Co., Ltd.
Why is Huaren Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 4.52%
  • The company has been able to generate a Return on Capital Employed (avg) of 4.52% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
  • Poor long term growth as Net Sales has grown by an annual rate of -2.54% and Operating profit at -275.58% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 5.13% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of -2.54% and Operating profit at -275.58% over the last 5 years
4
The company has declared Negative results for the last 4 consecutive quarters
  • NET SALES(HY) At CNY 613.3 MM has Grown at -19.27%
  • NET PROFIT(HY) At CNY 37.33 MM has Grown at -49.01%
  • ROCE(HY) Lowest at -68.83%
5
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -14.08%, its profits have fallen by -790.3%
  • At the current price, the company has a high dividend yield of 0
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Huaren Pharmaceutical Co., Ltd. for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Huaren Pharmaceutical Co., Ltd.
-11.22%
0.34
31.93%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-2.54%
EBIT Growth (5y)
-275.58%
EBIT to Interest (avg)
-0.31
Debt to EBITDA (avg)
3.20
Net Debt to Equity (avg)
1.08
Sales to Capital Employed (avg)
0.38
Tax Ratio
0.25%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.52%
ROE (avg)
5.13%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.34
EV to EBIT
-3.45
EV to EBITDA
-3.81
EV to Capital Employed
1.68
EV to Sales
3.73
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-48.67%
ROE (Latest)
-98.12%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -20.42% (YoY

PRE-TAX PROFIT(Q)

At CNY 24.59 MM has Grown at 107.52%

NET PROFIT(Q)

At CNY 21.3 MM has Grown at 106.48%

-20What is not working for the Company
NET SALES(HY)

At CNY 613.3 MM has Grown at -19.27%

NET PROFIT(HY)

At CNY 37.33 MM has Grown at -49.01%

ROCE(HY)

Lowest at -68.83%

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.77%

Here's what is working for Huaren Pharmaceutical Co., Ltd.
Pre-Tax Profit
At CNY 24.59 MM has Grown at 107.52%
over average net sales of the previous four periods of CNY -326.94 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 21.3 MM has Grown at 106.48%
over average net sales of the previous four periods of CNY -328.96 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Raw Material Cost
Fallen by -20.42% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Huaren Pharmaceutical Co., Ltd.
Net Sales
At CNY 613.3 MM has Grown at -19.27%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Inventory Turnover Ratio
Lowest at 2.77% and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."